More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Discover what data science is, its benefits, techniques, and real-world use cases in this comprehensive guide.

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

As FDA kicked off the drug user fee reauthorization process, Commissioner Marty Makary said he’d like to see lower fees paid ...

FDA announces sweeping changes to speed up the drug review process Subscribers are entitled to 10 gift sharing articles each month. These can be shared with friends and family who are not subscribers.

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback Provided by GlobeNewswire May 1, 2025, 2:30:00 PM ...

The FDA announced plans to reduce and potentially replace animal testing for developing monoclonal antibody therapies and other medications.

The US Food and Drug Administration (FDA) is launching a "stronger, more systematic" review process for chemicals in food.

The U.S. Food and Drug Administration (FDA) is set to significantly alter its approach to approving COVID-19 vaccines, a move that will primarily limit future vaccine recommendations to older ...

“The fact that [FDA commissioner Marty] Makary is a data-science guy that wants the data is actually very, very comforting to me because I don’t want medical products that will be used on me ...